Scientists Achieve a New Milestone: Six-Year Sustained HIV Remission in a German Patient

Scientists have marked a major breakthrough in medical science by achieving sustained HIV remission for six years in a 60-year-old man from Germany. This case represents the seventh documented instance in which long-term remission of HIV has been achieved, made possible through stem cell therapy. The findings were published in the prestigious journal Nature and are being widely recognized as a significant step forward in the ongoing search for a cure for HIV/AIDS.

For decades, HIV has been considered an incurable disease, requiring lifelong antiretroviral therapy to control viral replication. However, recent advances suggest that innovative medical approaches may eventually lead to durable remission and, potentially, eradication of the virus in selected cases.

Stem Cell Transplantation as a Therapeutic Strategy

The method used in this case involved a hematopoietic stem cell transplant. In earlier cases, two patients were successfully cured after receiving bone marrow transplants from donors carrying a rare genetic mutation known as CCR5-Δ32. This mutation alters the CCR5 receptor, which HIV commonly uses to enter immune cells, thereby providing natural resistance to infection.

However, this approach had not been effective in other patients, raising doubts about its broader applicability. Previously cured individuals had received transplants from donors who were homozygous for the CCR5-Δ32 mutation—meaning they carried two copies of the altered gene, a rare genetic profile found in only a small percentage of the population.

The Second “Berlin Patient” and Its Significance

In the newly reported case, often referred to as the second Berlin patient, researcher Christian Gaebler from the Berlin Institute of Health and the University of Berlin provided detailed insights into the treatment. The patient, who also suffered from leukemia, received a stem cell transplant from a donor who carried only one copy of the CCR5-Δ32 mutation.

This outcome is particularly important because it suggests that a much larger pool of potential donors could be effective in achieving HIV remission than previously believed. According to Javier Martínez-Picado, a member of the IciStem consortium—co-led by the IrsiCaixa AIDS Research Institute in Barcelona and the University Medical Center Utrecht—this study represents “high-quality, very detailed work” that reinforces earlier findings.

While the results confirm that remission can be achieved through hematopoietic stem cell transplantation, experts emphasize that this intervention remains strictly limited to patients with severe hematological diseases, such as leukemia, due to the high risks associated with the procedure.

Moving One Step Closer to a Cure

This is not the only promising research published recently. Nature has also featured two additional studies exploring alternative strategies to induce HIV remission.

One study, led by researchers at the University of California, San Francisco (UCSF), demonstrated that HIV may be controlled without continuous antiviral therapy by combining experimental immunotherapy agents. In this small trial, 7 out of 10 participants were able to maintain low viral levels for several months after discontinuing antiretroviral treatment. Although encouraging, the study was limited by its small sample size and the absence of a control group. Funding was provided by the AIDS Research Foundation (amfAR), with support from the U.S. National Institutes of Health (NIH).

The second study, led by David Collins of the Ragon Institute—a joint center of Harvard University and MIT—identified shared characteristics of T cells in individuals who demonstrated natural viral control in earlier clinical trials. These findings aim to inform future therapies designed to induce HIV remission by strengthening the immune system’s ability to suppress the virus.

Outlook for the Future

Together, these studies highlight meaningful progress toward long-term HIV remission and provide valuable insights for the development of safer, more accessible therapies. While stem cell transplantation is not a viable option for the vast majority of people living with HIV, the biological mechanisms uncovered through these cases are helping scientists move closer to treatments that could one day offer functional cures without the need for extreme medical interventions.